| Undifferentiated Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived72 of 72show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 42 trials (11 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 34 trials (10 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 20 trials (5 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenib/Trametinib Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |